Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
Giada Zurlo(University of North Carolina at Chapel Hill), Qing Zhang(Southwestern Medical Center), Baek Kim(University of Rochester), Jörgen Bierau(Maastricht University Medical Centre), Alex von Kriegsheim(Edinburgh Cancer Research), Mamoru Takada(University of North Carolina at Chapel Hill), Jason W. Locasale(Duke University), Charles M. Perou(University of North Carolina at Chapel Hill), Marie Zikánová(Charles University), Javier Rodríguez(Universidad de Cantabria), Travis Ptacek(University of North Carolina at Chapel Hill), Jing Zhang(Nanchang University), Mingjie Li(University of North Carolina at Chapel Hill), Xian Chen(University of North Carolina at Chapel Hill), Ling Xie(University of North Carolina at Chapel Hill), Xijuan Liu(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), Adam Robinson(University of North Carolina at Chapel Hill), Jeremy M. Simon(Harvard University), Juan Liu(Shandong University of Traditional Chinese Medicine), Jessica Holler(Emory University)
Cited by 48
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k